Antonio Leonardi
- Molecular Biology top 2%
- Cancer Research top 0.5%
- Immunology top 1%
- Oncology top 2%
- Epidemiology top 10%
- Co-authors
- Francesco PacificoUlrich SiebenlistGuido FranzosoKeith BrownLouise CarlsonElizabeth W. ShoresLjiljana PoljakSilvestro Formisano
- Topics
- NF-κB Signaling Pathways (32 papers)Immune Response and Inflammation (16 papers)Cell death mechanisms and regulation (14 papers)
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Experimental Medicine
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Antonio Leonardi
106 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 2.6k
- Cancer Research 1.7k
- Immunology 1.7k
- Oncology 1.1k
- Epidemiology 306
Countries citing papers authored by Antonio Leonardi
This map shows the geographic impact of Antonio Leonardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Leonardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Leonardi more than expected).
Fields of papers citing papers by Antonio Leonardi
This network shows the impact of papers produced by Antonio Leonardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Leonardi. The network helps show where Antonio Leonardi may publish in the future.
Co-authorship network of co-authors of Antonio Leonardi
This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Leonardi. A scholar is included among the top collaborators of Antonio Leonardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Leonardi. Antonio Leonardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 14 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 25 | |
| 6 | 14 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 17 | |
| 10 | 18 | |
| 11 | 49 | |
| 12 | 7 | |
| 13 | 48 | |
| 14 | 20 | |
| 15 | 20 | |
| 16 | 117 | |
| 17 | 23 | |
| 18 | 35 | |
| 19 | 21 | |
| 20 | 5 |
About Antonio Leonardi
Antonio Leonardi is a scholar working on Cancer Research, Immunology and Biotechnology, having authored 106 papers that have together received 4.8k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (32 papers), Immune Response and Inflammation (16 papers) and Cell death mechanisms and regulation (14 papers). The work is most often cited by research in Cancer Research (1.7k citations), Immunology (1.7k citations) and Oncology (1.1k citations). Antonio Leonardi has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Francesco Pacifico, Ulrich Siebenlist, Guido Franzoso, Keith Brown, Louise Carlson, Elizabeth W. Shores, Ljiljana Poljak, Silvestro Formisano, Pasquale Vito and Brendan F. Boyce. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.